anti-gpc3-irdye800cw
Showing 1 - 1 of 1
Hepatocellular Carcinoma Trial in Zhuhai, Luzhou (Anti-GPC3-IRDye800CW)
Recruiting
- Hepatocellular Carcinoma
- Anti-GPC3-IRDye800CW
-
Zhuhai, Guangdong, China
- +1 more
Sep 11, 2021